For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260416:nRSP7789Aa&default-theme=true
RNS Number : 7789A Geiger Counter Ltd 16 April 2026
THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE
PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS
AMENDED
Geiger Counter Limited (or the "Company")
16 April 2026
Director Subscriptions
Further to the announcement by the Company on 30 March 2026, in respect of the
right to subscribe for Ordinary Shares in the Company, the following directors
intend to exercise their subscription rights in respect of their shareholdings
as follows:
Director Position Total Ordinary Shares held Subscription Shares intended to subscribe for Amount (£)
Gary Clark Chairman 250,102 50,020 18,607
James Leahy Non Executive Director 114,194 22,838 8,496
Total 364,296 72,858 27,103
The Directors consider that the terms of the Director's subscriptions are fair
and reasonable insofar as shareholders are concerned.
Enquiries
Manulife | CQS Investment Management Craig Cleland T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited Tunga Chigovanyika T: +44 (0) 20 7397 1915
(Corporate Finance)
Daniel Balabanoff / Pauline Tribe (Sales) T: +44 (0) 20 7220 0500
Summit Fund Services Jersey Limited Christopher Foulds T:+44 (0) 1534 825 259
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCFZGMDLVNGVZG
Copyright 2019 Regulatory News Service, all rights reserved